{"entity":{"type":"insider","cik":"0001706667","url":"/insider/0001706667","json_url":"/insider/0001706667.json","name":"Moses Jennifer K.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2018-01-08","last":"2023-01-05","span_basis":"filed_date"},"name_variants":[{"name":"Moses Jennifer K.","source":"filing","n_filings":14,"first_seen":"2018-01-08","last_seen":"2023-01-05"}],"transactions":[{"id":7933094,"accession":"0001562180-23-000255","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-000255","line_url":"/filing/0001562180-23-000255#line-3","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":729.0,"shares_display":"729","price_per_share":5.4075,"price_display":"5.41","price_state":"stated","total_value":3942.0675,"total_display":"3,942.07","total_whole":"3,942","shares_owned_after":57820.0,"shares_owned_after_display":"57,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-05","scope":"insider"},{"id":7933090,"accession":"0001562180-23-000255","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-23-000255","line_url":"/filing/0001562180-23-000255#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1639.0,"shares_display":"1,639","price_per_share":5.5756,"price_display":"5.58","price_state":"stated","total_value":9138.4084,"total_display":"9,138.41","total_whole":"9,138","shares_owned_after":58549.0,"shares_owned_after_display":"58,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-05","scope":"insider"},{"id":6428752,"accession":"0001562180-22-000306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-000306","line_url":"/filing/0001562180-22-000306#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (CFO)","role_mark":"O","role_mark_label":"Officer (CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1445.0,"shares_display":"1,445","price_per_share":10.6115,"price_display":"10.61","price_state":"stated","total_value":15333.6175,"total_display":"15,333.62","total_whole":"15,334","shares_owned_after":35555.0,"shares_owned_after_display":"35,555","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-05","filed_date":"2022-01-05","scope":"insider"},{"id":6550695,"accession":"0001562180-18-004886","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004886","line_url":"/filing/0001562180-18-004886#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":34.0,"price_display":"34.00","price_state":"stated","total_value":25500.0,"total_display":"25,500.00","total_whole":"25,500","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-07","scope":"insider"},{"id":6550608,"accession":"0001562180-18-004453","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004453","line_url":"/filing/0001562180-18-004453#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":41.38,"price_display":"41.38","price_state":"stated","total_value":31035.0,"total_display":"31,035.00","total_whole":"31,035","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-05","filed_date":"2018-11-07","scope":"insider"},{"id":6755630,"accession":"0001562180-18-004208","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-004208","line_url":"/filing/0001562180-18-004208#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":44.52,"price_display":"44.52","price_state":"stated","total_value":33390.0,"total_display":"33,390.00","total_whole":"33,390","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-08","filed_date":"2018-10-10","scope":"insider"},{"id":6424643,"accession":"0001562180-18-003854","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-003854","line_url":"/filing/0001562180-18-003854#line-3","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":59.6,"price_display":"59.60","price_state":"stated","total_value":44700.0,"total_display":"44,700.00","total_whole":"44,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-05","filed_date":"2018-09-06","scope":"insider"},{"id":6739199,"accession":"0001562180-18-003499","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-003499","line_url":"/filing/0001562180-18-003499#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":50.79,"price_display":"50.79","price_state":"stated","total_value":38092.5,"total_display":"38,092.50","total_whole":"38,093","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-06","filed_date":"2018-08-06","scope":"insider"},{"id":6880085,"accession":"0001562180-18-003237","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-003237","line_url":"/filing/0001562180-18-003237#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":45.66,"price_display":"45.66","price_state":"stated","total_value":34245.0,"total_display":"34,245.00","total_whole":"34,245","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-05","filed_date":"2018-07-05","scope":"insider"},{"id":5988358,"accession":"0001562180-18-002856","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-002856","line_url":"/filing/0001562180-18-002856#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":38.77,"price_display":"38.77","price_state":"stated","total_value":29077.5,"total_display":"29,077.50","total_whole":"29,078","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-05","scope":"insider"},{"id":6705045,"accession":"0001562180-18-002313","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-002313","line_url":"/filing/0001562180-18-002313#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":33750.0,"total_display":"33,750.00","total_whole":"33,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-07","scope":"insider"},{"id":6641401,"accession":"0001562180-18-001868","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001868","line_url":"/filing/0001562180-18-001868#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":37.47,"price_display":"37.47","price_state":"stated","total_value":28102.5,"total_display":"28,102.50","total_whole":"28,103","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-05","filed_date":"2018-04-05","scope":"insider"},{"id":6504739,"accession":"0001562180-18-001485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001485","line_url":"/filing/0001562180-18-001485#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":26.55,"price_display":"26.55","price_state":"stated","total_value":19912.5,"total_display":"19,912.50","total_whole":"19,913","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-06","scope":"insider"},{"id":5988185,"accession":"0001562180-18-000626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-000626","line_url":"/filing/0001562180-18-000626#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":22.99,"price_display":"22.99","price_state":"stated","total_value":17242.5,"total_display":"17,242.50","total_whole":"17,243","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-06","scope":"insider"},{"id":6244949,"accession":"0001562180-18-000248","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-000248","line_url":"/filing/0001562180-18-000248#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706667","owner_name":"Moses Jennifer K.","owner_display_name":"Moses Jennifer K.","owner_url":"/insider/0001706667","role":"Officer (VP of Finance & Admin)","role_mark":"O","role_mark_label":"Officer (VP of Finance & Admin)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Finance & Admin","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":750.0,"shares_display":"750","price_per_share":19.96,"price_display":"19.96","price_state":"stated","total_value":14970.0,"total_display":"14,970.00","total_whole":"14,970","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Officer (CFO)","n_filings":14,"first_seen":"2018-01-08","last_seen":"2023-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706667","retrieved_at":"2026-08-23T03:04:09+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}